Abstract:Anti-doping authorities have high expectations of the athlete steroidal passport (ASP) for anabolic-androgenic steroids misuse detection. However, it is still limited to the monitoring of known well-established compounds and might greatly benefit from the discovery of new relevant biomarkers candidates. In this context, steroidomics opens the way to the untargeted simultaneous evaluation of a high number of compounds. Analytical platforms associating the performance of ultra-high pressure liquid chromatography (UHPLC) and the high mass-resolving power of quadrupole time-of-flight (QTOF) mass spectrometers are particularly adapted for such purpose. An untargeted steroidomic approach was proposed to analyse urine samples from a clinical trial for the discovery of relevant biomarkers of testosterone undecanoate oral intake. Automatic peak detection was performed and a filter of reference steroid metabolites mass-to-charge ratio (m/z) values was applied to the raw data to ensure the selection of a subset of steroid-related features. Chemometric tools were applied for the filtering and the analysis of UHPLC-QTOF-MS(E) data. Time kinetics could be assessed with N-way projections to latent structures discriminant analysis (N-PLS-DA) and a detection window was confirmed. Orthogonal projections to latent structures discriminant analysis (O-PLS-DA) classification models were evaluated in a second step to assess the predictive power of both known metabolites and unknown compounds. A shared and unique structure plot (SUS-plot) analysis was performed to select the most promising unknown candidates and receiver operating characteristic (ROC) curves were computed to assess specificity criteria applied in routine doping control. This approach underlined the pertinence to monitor both glucuronide and sulphate steroid conjugates and include them in the athletes passport, while promising biomarkers were also highlighted.

Design and preparation of the protein chip for doping detection

Development of Miniaturized Competitive Immunoassays on a Protein Chip As a Screening Tool for Drugs.

Protein Chips for High-Throughput Doping Screening in Athletes

Preparation and Application of Biochip for Detection of Various Antigens in Stool

Hydrophilic/hydrophobic modified microchip for detecting multiple gene doping candidates using CRISPR-Cas12a and RPA

Research On Protein Chip Technologies For The Detection Of Atrazine And Papaverine

Multi-analyte screening of small peptides by alkaline pre-activated solid phase extraction coupled with liquid chromatography-high resolution mass spectrometry in doping controls

A steroidomic approach for biomarkers discovery in doping control

Rapid and ultra-sensitive testosterone detection via aptamer-functional gold nanoparticles

Novel probes for protein chip applications.

A Rapid Capillary Zone Electrophoresis Method for Simultaneous Determination of Several Kinds of Doping Agents

Advanced Immobilization and Amplification for High Performance Protein Chips

Doping Control Analysis of Small Peptides in Human Urine Using LC-HRMS with Parallel Reaction Monitoring Mode: Screening and Confirmation.

A Microfluidic Chip with Integrated Microelectrodes for Real-time Dopamine Detection

Label-Free and Ultra-Sensitive Detection of Dexamethasone Using a FRET Aptasensor Utilizing Cationic Conjugated Polymers

Probing for peptidic drugs (2-10 kDa) in doping control blood samples

Microfluidic Chip For Methamphetamine Detection Based On Time-Resolved Fluoroimmunoassay

Sensitive electrochemical detection of doping agent metoprolol between athletes via copper phthalocyanine-modified graphitic carbon nitride electrode: a versatile approach for doping surveillance in food products and biological fluids

Preparation of steroid antibodies and parallel detection of multianabolic steroid abuse with conjugated hapten microarray.

From High Efficient Protein Micro Chip Toward Ultra High Sensitive Single Molecule Nano Array

Microelectrode array biochip: tool for in vitro drug screening based on the detection of a drug effect on dopamine release from PC12 cells.